-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Arrowhead Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q4 2017 to Q4 2023.
- Arrowhead Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending December 31, 2023 was $64.8M.
- Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$96.2M, a 1675% decline from 2022.
- Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$5.42M, a 96.2% increase from 2021.
- Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$142M, a 41.2% increase from 2020.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)